Denmark's Export and Investment Fund (EIFO) and the Novo Nordisk Foundation (NNF) are set to invest €80 million ($92.93m) to ...

The Danish government and the foundation behind Novo Nordisk A/S will invest €80 million ($93 million) in a Microsoft-powered ...

COPENHAGEN, Denmark, Dec. 8, 2020 /PRNewswire/ -- The Novo Nordisk Foundation today announces that BioInnovation Institute (BII), a Novo Nordisk F ...

LONDON (Reuters) - The Novo Nordisk Foundation does not plan to step in to prop up a global health sector reeling from a freeze on U.S.-funded foreign aid, and will continue to focus on its core ...

Denmark is investing 80 million euro in a quantum computing project intended to bring a commercial-grade system to the Nordic ...

A multi-ancestry polygenic risk score could help health care professionals predict a person’s risk for developing obesity ...

The Novo Nordisk Foundation is considered a “shareholder foundation” or “enterprise foundation,” meaning that it controls a majority stake in the corporate entities Novo Nordisk and Novozymes. That ...

The Novo Nordisk Foundation, top shareholder of Danish obesity drugmaker Novo Nordisk, plans to give a larger portion of its social, scientific and humanitarian grants outside of Denmark, ...

The Novo Nordisk Foundation, the philanthropic fund behind the maker of blockbuster drugs Ozempic and Wegovy, will give more donations to stem-cell based therapies as part of a shift in its focus ...

Novo Nordisk Foundation's nine-person board includes former Novo CEO and current board chairman Lars Rebien Sørensen, University of Copenhagen professor Liselotte Højgaard, ...

Novo Nordisk’s main shareholder — the Novo Nordisk Foundation — initiated the move. The century-old nonprofit foundation has 75% of the voting rights and holds just under a third of the ...